On May 17, 2023, Zymeworks Inc. and Mr. Neil Klompas, the Company's President and Chief Operating Officer, mutually agreed to terms pursuant to which Mr. Klompas will step down as the Company's President and Chief Operating Officer and separate from employment effective as of June 30, 2023 (the Separation Effective Date).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.06 USD | -3.41% | +3.18% | -12.51% |
May. 02 | Transcript : Zymeworks Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.51% | 669M | |
+8.67% | 114B | |
+11.25% | 104B | |
-12.66% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.96% | 17.89B | |
+7.90% | 14.28B | |
+35.40% | 12.55B |
- Stock Market
- Equities
- ZYME Stock
- News Zymeworks Inc.
- Zymeworks Inc. Announces Executive Changes